Brian B Kennedy

US Patent:

20210000599, Jan 7, 2021

Filed:

Jul 2, 2020

Appl. No.:

16/919806

Inventors:

- Maple Grove MN, US
Joel T. Eggert - Plymouth MN, US
James P. Rohl - Prescott WI, US
Aaron Abbott - Columbia Hieghts MN, US
Christopher J. Koudela - New London MN, US
Brian Kennedy - Mora MN, US
Joseph Walker - Shoreview MN, US
Douglas Pennington - Stillwater MN, US

International Classification:

A61F 2/24

Abstract:

The present disclosure relates generally to the field of medical devices for treating heart disease. In particular, the present disclosure relates to medical devices, systems, and methods for delivering artificial chordae tendineae in a patient. A system for delivering a chordae tendineae into a heart may include a delivery catheter. A clamp catheter may be configured to translate through the delivery catheter. A spreader may be disposed on the clamp catheter. A first clamp may be at least partially contained in the spreader in a closed configuration and may be attached to the chordae tendineae. An anchor catheter may be configured to translate through the delivery catheter and may have an anchor attached to the chordae tendineae. A sheath may be extended over the anchor catheter and anchor and may be configured to restrain an arm of the anchor.

US Patent:

20200404034, Dec 24, 2020

Filed:

May 7, 2020

Appl. No.:

16/869137

Inventors:

- Burbank CA, US
Zachary N. Toback - Montclair NJ, US
Ryan N. McCormick - Blauvelt NY, US
Craig L. Beardsley - Chicago IL, US
Brian M. Kennedy - New York NY, US

International Classification:

H04L 29/06

Abstract:

A hybrid cloud-based media production system includes a facility extension platform having a hardware processor and a memory storing a software code. The hardware processor executes the software code to identify multicast production media flow(s) for processing in a cloud-based virtual production environment, to identify cloud-based resource(s) for processing one or more cloud production media flow(s) corresponding to the multicast production media flow(s), in the cloud-based virtual production environment, and to coordinate provisioning of the cloud-based virtual production environment with the identified cloud-based resource(s). The hardware processor also executes the software code to align, using a cloud permissible timing protocol, the timing of the cloud production media flow(s) in the cloud-based virtual production environment, and to process the cloud production media flow(s) in the cloud-based virtual production environment using the identified cloud-based resource(s).

US Patent:

20150227702, Aug 13, 2015

Filed:

Feb 9, 2015

Appl. No.:

14/617708

Inventors:

- New York NY, US
Fatih Sirin - New York NY, US
Dhinakaran Chinappen - Sunnyside NY, US
Robert Callan - New York NY, US
William C. Bubel - Bronx NY, US
Brian Kennedy - Cortlandt Manor NY, US

International Classification:

G06F 19/00

Abstract:

A medical imaging decision support system is provided that can conduct, and help medical professionals conduct multi-factor brain analysis. Data for disparate processing modes (for example, EEG, MRI, etc.) can be input to the system, processed in parallel in a cloud environment, and the results can be rendered in a thin client (for example, browser) for a user's rapid multi-modal evaluation of a brain.

US Patent:

20150175681, Jun 25, 2015

Filed:

Mar 9, 2015

Appl. No.:

14/642342

Inventors:

- Tarrytown NY, US
Kirsten Nagashima - Valhalla NY, US
Brian Kennedy - Yorktown Heights NY, US
Gerald P. Donovan - Kittery ME, US
Yun Kang - Livingstone NJ, US
William C. Olson - Yorktown Heights NY, US
Shankar Kumar - Pleasanton CA, US
Naoya Tsurushita - Palo Alto CA, US
Andre J. Marozsan - Port Chester NY, US
Albert Cupo - Stamford CT, US

International Classification:

C07K 16/12
A61K 39/40

Abstract:

Provided herein are reagents, compositions, and therapies with which to treat infection and related disease conditions and pathologies, such as -associated diarrhea, resulting from infection by bacteria and the enterotoxins produced by these bacteria. In particular, antibodies or antigen-binding fragments thereof that bind specifically to toxin A and/or toxin B of and neutralize the activities of these toxins; compositions comprising such antibodies; and methods of using the antibodies and the compositions are provided.